×

CE7-specific redirected immune cells

  • US 7,070,995 B2
  • Filed: 04/11/2002
  • Issued: 07/04/2006
  • Est. Priority Date: 04/11/2001
  • Status: Active Grant
First Claim
Patent Images

1. Genetically engineered human CE7-specific T cells which express and bear on the cell surface membrane a CE7-specific chimeric receptor comprising at least one intracellular signaling domain, at least one transmembrane domain and at least one extracellular domain, wherein the extracellular domain comprises a CE7-specific receptor and wherein the CE7-specific chimeric receptor comprises amino acids 21–

  • 631 of SEQ ID NO;

    2.

View all claims
  • 1 Assignment
Timeline View
Assignment View
    ×
    ×